Company Filing History:
2 out of 1,736 
1 out of 1 Years Active: 2021-2025
Title: Lina Franco Achury: Innovator in Oncolytic Virus Research
Introduction
Lina Franco Achury is a prominent inventor based in Tempe, AZ (US), known for her groundbreaking work in the field of cancer treatment. With a total of 2 patents, she has made significant contributions to the development of oncolytic virus platforms utilizing myxoma virus technology.
Latest Patents
Her latest patents focus on the use of recombinant myxoma viruses (MYXVs) to treat various cancers. These patents disclose methods for engineering MYXVs to inactivate or attenuate the activity of the M153 protein. Additionally, the MYXVs are designed to express transgenes such as tumor necrosis factor (TNF), interleukin-12 (IL-12), or decorin. The patents also outline methods for administering these MYXVs to subjects in need of treatment.
Career Highlights
Lina has worked with notable organizations, including Arizona State University and Oncomyx Therapeutics, Inc. Her research has been pivotal in advancing the understanding and application of oncolytic viruses in oncology.
Collaborations
Throughout her career, Lina has collaborated with esteemed colleagues such as Douglas Grant McFadden and Mohammed Masmudur Rahman. These partnerships have further enriched her research and innovation in the field.
Conclusion
Lina Franco Achury stands out as a key figure in the development of innovative cancer therapies through her work with myxoma viruses. Her contributions continue to pave the way for new treatment options in oncology.